Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,195 | -6,097 | -4,516 | -4,687 | -5,237 |
| Depreciation Amortization | 6,006 | 4,060 | 2,009 | 8,118 | 6,073 |
| Income taxes - deferred | 29 | 423 | N/A | -398 | N/A |
| Accounts receivable | 6,805 | 5,855 | 5,149 | 468 | 3,805 |
| Accounts payable and accrued liabilities | 586 | 1,925 | 2,739 | -2,048 | -2,059 |
| Other Working Capital | 5,360 | 5,296 | 4,747 | 42 | 960 |
| Other Operating Activity | -4,750 | -6,218 | -7,257 | 6,550 | 2,283 |
| Operating Cash Flow | $6,841 | $5,244 | $2,871 | $8,045 | $5,825 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,088 | -524 | -241 | -1,216 | -778 |
| Net Acquisitions | N/A | N/A | N/A | 1,002 | 1,020 |
| Other Investing Activity | 0 | 0 | 0 | -15 | -15 |
| Investing Cash Flow | $-1,088 | $-524 | $-241 | $-229 | $227 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,615 | 6,115 | N/A | 4,300 | 4,300 |
| Debt Repayment | -20,251 | -16,411 | -4,829 | -11,703 | -11,103 |
| Common Stock Issued | 194 | 187 | -242 | -221 | -392 |
| Other Financing Activity | -882 | -262 | 0 | 0 | 0 |
| Financing Cash Flow | $-11,324 | $-10,371 | $-5,071 | $-7,624 | $-7,195 |
| Exchange Rate Effect | 42 | -55 | -12 | -30 | -185 |
| Beginning Cash Position | 8,335 | 8,335 | 8,335 | 8,173 | 8,173 |
| End Cash Position | 2,806 | 2,629 | 5,882 | 8,335 | 6,845 |
| Net Cash Flow | $-5,529 | $-5,706 | $-2,453 | $162 | $-1,328 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,841 | 5,244 | 2,871 | 8,045 | 5,825 |
| Capital Expenditure | -1,088 | -524 | -241 | -1,216 | -778 |
| Free Cash Flow | 5,753 | 4,720 | 2,630 | 6,829 | 5,047 |